This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pratik Maroo, Head of Healthcare and LifeSciences at Zensar It is estimated that the value of medical IoT devices will be $467.25 billion by 2027. The pandemic accelerated the adoption of emerging regulations to expedite the use of IoT in the medical world.
As we see price transparency legislation take shape through 2027 and beyond, Turquoise accelerates support for healthcare organizations as they embed transparency and simplicity at every step in the transaction,” says Turquoise CEO, Chris Severn. Learn more at turquoise.health.
Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027.
At Doceree, we shall remain dedicated to enriching HCP-patient engagement, strengthening global partnerships, and empowering the lifesciences sector to reach new milestones responsibly and ethically. Kent Dicks, Chief Executive Officer at Life 365 Healthcare costs in the U.S.
Between 2020 and 2027, retail drug spending under private health insurance is projected to increase at a rate of 3 percent to 6 percent a year as the impact of generics on spending plateaus, biosimilars continue to see slow uptake, and costly new therapies enter the market. WHAT’S THE IMPACT. One is that drug spending will grow faster.
The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027. Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research.
Studies More than 80% of healthcare and lifescience organizations with mature AI adoption have increased revenue and improved customer satisfaction , according to the results of a survey from Vultr. Luke’s University Health Network the recipient of its inaugural “Analytics in Action Designation of Excellence” award.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content